Concepedia

Carl Coeck

CC

Statistics

Publications

10

Citations

2.8K

H-Index

10

Active since

1997

Affiliations

Boehringer Ingelheim (Belgium)(Current)

Boehringer Ingelheim (Germany)

Hôpital Louis Pradel

Université Claude Bernard Lyon 1

Hospices Civils de Lyon

Carl Coeck is an author at Boehringer Ingelheim (Belgium) specializing in pharmacotherapy, pulmonology, and pulmonary function testing.

Publications per year

1997–2025

10

Publications

10

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

, , +11

Nerandomilast in Patients with Progressive Pulmonary Fibrosis

Toby M. Maher, Shervin Assassi, Arata Azuma et al. · New England Journal of Medicine · 2025 · 139 citations · Full text

, , +13

Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™).

Oliver Distler, Kevin K. Brown, Jörg H. W. Distler et al. · PubMed · 2017 · 70 citations

, , +15

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

Vincent Cottin, Luca Richeldi, Iván O. Rosas et al. · Respiratory Research · 2021 · 70 citations · Full text

, , +13

Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial

Vincent Cottin, Fernando J. Martinez, Gísli Jenkins et al. · Respiratory Research · 2022 · 48 citations · Full text

, , +13

1–5 of 10